![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1503382
¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ½ÃÀå ¿¹Ãø(-2030³â) : Á¦Ç°, ¼ºñ½º, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº° ¼¼°è ºÐ¼®Remote Patient Monitoring Market Forecasts to 2030 - Global Analysis By Product (Wearable Devices, Mobile Devices, Telehealth, Remote Monitoring Devices and Other Products), Service, Application, End User and By Geography |
Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ½ÃÀåÀº 2024³â¿¡ 725¾ï 2,000¸¸ ´Þ·¯¸¦ Â÷ÁöÇÏ°í ¿¹Ãø ±â°£ Áß CAGRÀº 25.6%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 2,105¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀº ÀÇ·á Àü¹®°¡°¡ ±âÁ¸ ÀÓ»ó ȯ°æ ¹Û¿¡¼ ȯÀÚ¸¦ ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â ÇコÄÉ¾î ±â¼úÀÔ´Ï´Ù. µðÁöÅÐ ±â±â¸¦ ÅëÇØ ȯÀڷκÎÅÍ »ýü ½ÅÈ£, Áõ»ó ¹× ±âŸ °Ç° ÁöÇ¥¿Í °°Àº ÀÇ·á µ¥ÀÌÅ͸¦ ½Ç½Ã°£À¸·Î ¼öÁýÇÕ´Ï´Ù. ÀÌ Á¤º¸´Â ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô ¾ÈÀüÇÏ°Ô Àü¼ÛµÇ¾î Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ°ú ÇÊ¿äÇÑ °æ¿ì Àû±ØÀûÀÎ °³ÀÔÀ» °¡´ÉÇϰÔÇÕ´Ï´Ù. RPMÀº °Ç° ¹®Á¦¸¦ Á¶±â¿¡ ¹ß°ßÇϰí Ä¡·á ¼øÀÀµµ¸¦ ³ôÀÌ¸ç ºó¹øÇÑ º´¿ø ¹æ¹®ÀÇ Çʿ伺À» ÁÙÀÓÀ¸·Î½á ȯÀÚ Ä¡·á¸¦ °³¼±ÇÕ´Ï´Ù.
¹Ì±¹ Áúº´¿¹¹æÅëÁ¦¼¾ÅÍ(CDC)¿¡ µû¸£¸é ¹Ì±¹¿¡¼´Â 1¾ï ¸í ÀÌ»óÀÌ °íÇ÷¾ÐÀ» ¾Î°í ÀÖÀ¸¸ç, ¹Ì±¹½ÉÀåÇùȸ(AHA)´Â ´õ ³ªÀº °Ç°°ü¸®¸¦ À§ÇØ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ±â¼ú(RPM)ÀÇ È°¿ë ±âȸ¸¦ ´Ã¸®±â À§ÇÑ ³ë·ÂÀ» ÁöÁöÇϰí ÀÖ½À´Ï´Ù.
¸¸¼ºÁúȯ Áõ°¡
´ç´¢º´, ½ÉÇ÷°ü ¹× È£Èí±â Áúȯ°ú °°Àº ¸¸¼ºÁúȯÀÇ Àü ¼¼°è À¯º´·ü Áõ°¡·Î ÀÎÇØ ÀüÅëÀûÀÎ ÀÇ·á ȯ°æ ¹Û¿¡¼ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ ¹× °ü¸®¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¸é¼ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM)ÀÇ ¼ºÀåÀÌ °¡¼Óȵǰí ÀÖ½À´Ï´Ù. ¸Å°³º¯¼ö¸¦ ¿ø°Ý¿¡¼ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÏ¿© °Ç° ¾Çȸ¦ Á¶±â¿¡ ¹ß°ßÇϰí Àû½Ã¿¡ °³ÀÔÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÀÌ·¯ÇÑ »çÀü ¿¹¹æÀû Á¢±Ù ¹æ½ÄÀº ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÒ »Ó¸¸ ¾Æ´Ï¶ó ¿¹¹æ °¡´ÉÇÑ ÀÔ¿ø ¹× ÀÀ±Þ½Ç ¹æ¹®°ú °ü·ÃµÈ ÀÇ·á ºñ¿ëÀ» Àý°¨ÇÏ¿© RPMÀ» ¸¸¼ºÁúȯ °ü¸® Àü·«¿¡ ÇʼöÀûÀÎ Åø·Î Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù.
Á¦ÇÑÀûÀÎ »óȯ Á¤Ã¥
¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM)ÀÇ Á¦ÇÑÀûÀÎ »óȯ Á¤Ã¥Àº ´Ù¾çÇÑ RPM ¼ºñ½º¿Í ±â¼úÀ» °í·ÁÇÑ Ç¥ÁØÈµÈ »óȯ ÇÁ·¹ÀÓ¿öÅ©¸¦ È®¸³ÇÏ´Â µ¥ ¾î·Á¿òÀ» °Þ°í ÀÖ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ÀÌ·¯ÇÑ Á¤Ã¥Àº Áö¿ª°ú ÁöºÒÀÚ¸¶´Ù Å©°Ô ´Ù¸£±â ¶§¹®¿¡ RPM ¼ºñ½ºÀÇ Àû¿ë ¹üÀ§°¡ ºÒºÐ¸íÇϰí Àϰü¼ºÀÌ ºÎÁ·ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¸íÈ®Çϰí Á¾ÇÕÀûÀÎ º¸Çè »óȯÀÇ ºÎÁ·Àº ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿Í Á¶Á÷ÀÌ RPM ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÁÖÀúÇÏ°Ô ¸¸µé°í, ½ÃÀå äÅðú Çõ½ÅÀ» Áö¿¬½ÃŰ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.
°í·É Àα¸ Áõ°¡
³ëÀÎ Àα¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ°ú °ü¸®°¡ ÇÊ¿äÇÑ ¸¸¼ºÁúȯ ¹× ³ëÈ °ü·Ã °Ç° ¹®Á¦°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, RPM ±â¼úÀ» ÅëÇØ ÀÇ·áÁøÀº Ȱ·Â ¡ÈÄ, ¾à¹° ¼øÀÀµµ ¹× Àü¹ÝÀûÀÎ °Ç° »óŸ¦ ¿ø°ÝÀ¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖÀ¸¸ç, Á¶±â °³ÀÔ°ú ¸ÂÃã Ä¡·á°¡ ¿ëÀÌÇØÁ³½À´Ï´Ù.¸¦ ½±°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ±â´ÉÀº ³ëÀÎÀÇ °Ç° »óŸ¦ °³¼±ÇÒ »Ó¸¸ ¾Æ´Ï¶ó ÀæÀº º´¿ø ¹æ¹®°ú ÀÔ¿øÀÇ Çʿ伺À» ÁÙÀÓÀ¸·Î½á ³ëÀÎÀÇ »îÀÇ ÁúÀ» Çâ»ó½ÃÄÑ °í·ÉÈ ¹®Á¦¸¦ È¿À²ÀûÀÌ°í ºñ¿ë È¿À²ÀûÀ¸·Î ÇØ°áÇÒ ¼ö ÀÖ½À´Ï´Ù.
±â¼úÀû Àå¾Ö¹°
¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÇ ±â¼úÀû À庮¿¡´Â ¿¬°á¼º, ¼·Î ´Ù¸¥ ±â±â ¹× ½Ã½ºÅÛ °£ÀÇ »óÈ£ ¿î¿ë¼º, µ¥ÀÌÅÍ º¸¾È ¹× ÇÁ¶óÀ̹ö½Ã º¸Àå µîÀÇ ¹®Á¦°¡ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ À庮Àº ¿øÈ°ÇÑ µ¥ÀÌÅÍ Àü¼Û°ú ½Ç½Ã°£ ¸ð´ÏÅ͸µÀ» ¹æÇØÇϰí RPM ¼Ö·ç¼ÇÀÇ ½Å·Ú¼º°ú È¿°ú¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ »õ·Î¿î ±â¼úÀÇ »ç¿ëÀÚ ¼ö¿ë¼º ¹× »ç¿ë¼º ¹®Á¦´Â ÀÇ·á ÇÁ·Î¹ÙÀÌ´õ¿Í ȯÀÚÀÇ Ã¤Å÷üÀ» ³·Ãâ ¼ö ÀÖ½À´Ï´Ù.
COVID-19ÀÇ ¿µÇâ
COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ ÀÇ·áÁøÀÌ ´ë¸é Áø·á¸¦ ÃÖ¼ÒÈÇÏ°í ³ëÃâ À§ÇèÀ» ÁÙÀÌ·Á°í ³ë·ÂÇÏ¸é¼ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇßÀ¸¸ç, RPMÀº COVID-19 ȯÀÚÀÇ È°·Â ¡ÈÄ¿Í Áõ»óÀ» ¿ø°ÝÀ¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖÀ¸¹Ç·Î äÅÃÀÌ ±ÞÁõÇß½À´Ï´Ù. ÀÌ´Â RPM ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃÄÑ ½ÃÀå ¼ºÀå°ú ±â¼ú Çõ½ÅÀ» ÃËÁøÇß½À´Ï´Ù. ¶ÇÇÑ À§±â ¹ß»ý½Ã ÀÇ·á ¼ºñ½º Á¦°ø °ü¸®¿¡¼ RPMÀÇ ÀáÀç·ÂÀ» ºÎ°¢½ÃÄÑ Àü¿°º´ ¿ÜÀÇ ´Ù¸¥ ¿ëµµ·Îµµ È®´ëµÇ¾ú½À´Ï´Ù.
¿¹Ãø ±â°£ Áß ¿þ¾î·¯ºí ±â±â ºÐ¾ß°¡ °¡Àå Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿þ¾î·¯ºí ±â±â ºÐ¾ß´Â ÇâÈÄ¿¡µµ ³ôÀº ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿þ¾î·¯ºí ±â±â´Â ½É¹Ú¼ö, Ç÷¾Ð, Ȱµ¿·® µî »ýü ½ÅÈ£¸¦ Áö¼ÓÀûÀ¸·Î ÃßÀûÇÔÀ¸·Î½á ȯÀÚÀÇ ¿ø°Ý ¸ð´ÏÅ͸µ¿¡ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ ȯÀÚÀÇ °Ç°À» ½Ç½Ã°£À¸·Î ¿ø°ÝÀ¸·Î ¸ð´ÏÅ͸µÇÏ¿© ÀÌ»ó ¡Èĸ¦ Á¶±â¿¡ ¹ß°ßÇϰí ÇÊ¿äÇÑ °æ¿ì ½Å¼ÓÇÏ°Ô °³ÀÔÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±â´Â °Ç° µ¿Çâ¿¡ ´ëÇÑ µ¥ÀÌÅͺ£À̽º ÀλçÀÌÆ®À» Á¦°øÇϰí, °³ÀÎÈµÈ Ä¡·á °èȹÀ» ÃËÁøÇÏ¿© ȯÀÚ Ä¡·á¸¦ °ÈÇϸç, ±Ã±ØÀûÀ¸·Î °á°ú¸¦ °³¼±Çϰí ÀÇ·á ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.
¸¸¼ºÁúȯ °ü¸® ¼ºñ½º ºÐ¾ß´Â ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¸¸¼ºÁúȯ °ü¸® ¼ºñ½º ºÐ¾ß´Â ¿¹Ãø ±â°£ Áß °¡Àå ºü¸¥ CAGR ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀº ¸Ö¸® ¶³¾îÁø °÷¿¡¼ ȯÀÚÀÇ °Ç° µ¥ÀÌÅ͸¦ Áö¼ÓÀûÀ¸·Î ÃßÀûÇÏ¿© ¿¹¹æÀû Ä¡·á¸¦ °ÈÇÕ´Ï´Ù. ÀÌ Á¢±Ù ¹æ½ÄÀº ¿þ¾î·¯ºí ±â±â ¹× ¸ð¹ÙÀÏ ¾Û°ú °°Àº µðÁöÅÐ ±â¼úÀ» Ȱ¿ëÇÏ¿© Ȱ·Â ¡ÈÄ¿Í Áõ»óÀ» ¿ø°ÝÀ¸·Î ¸ð´ÏÅ͸µÇÕ´Ï´Ù. ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â Á¶±â¿¡ °³ÀÔÇÏ¿© ÀÔ¿øÀ» ÁÙÀ̰í ȯÀÚÀÇ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ´ç´¢º´, °íÇ÷¾Ð, ½ÉÀ庴 µîÀÇ Áõ»óÀ» È¿À²ÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖ´Â Çö´ë ÀÇÇÐÀÇ À¯¸ÁÇÑ Àü·«ÀÔ´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼´Â ÀÇ·áºñ Áõ°¡, ¸¸¼ºÁúȯÀÇ À¯Çà, ÀÇ·á±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀϺ», Áß±¹, Àεµ, È£ÁÖ µîÀÇ ±¹°¡¿¡¼´Â ³ëÀÎ Àα¸ Áõ°¡¿Í È¿À²ÀûÀÎ ÀÇ·á °ü¸®ÀÇ Çʿ伺À¸·Î ÀÎÇØ RPM ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ µÎµå·¯Áö°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀ» Àå·ÁÇÏ´Â Á¤ºÎÀÇ ±¸»óÀº ½ÃÀå È®´ë¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀº ±â¼ú ¹ßÀü°ú Áö¼ÓÀûÀÎ ÀÇ·á °³ÇõÀ¸·Î ÀÎÇØ Áö¼ÓÀûÀÎ ¼ºÀåÀÌ ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.
ºÏ¹Ì¿¡¼´Â ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ½ÃÀåÀÌ °ß°íÇÏ°í ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ³ôÀº ¼öÁØÀÇ ÀÇ·á ÀÎÇÁ¶ó, À¯¸®ÇÑ »óȯ Á¤Ã¥, ´ç´¢º´ ¹× ½ÉÇ÷°ü Áúȯ°ú °°Àº ¸¸¼ºÁúȯÀÇ ³ôÀº À¯º´·ü·Î ÀÎÇØ RPM µµÀÔ¿¡ ÀÖÀ¸¸ç, ¼¼°è¸¦ ¼±µµÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹°ú ij³ª´Ù´Â ÀÇ·áºñ Áõ°¡¿Í °¡Ä¡ ±â¹Ý Ä¡·á ¸ðµ¨·ÎÀÇ ÀüȯÀ» ¹è°æÀ¸·Î ½ÃÀå ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ±â¼ú Çõ½ÅÀÌ Æ¯Â¡À̸ç, ±â¼ú ¹× ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©ÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀÌ ¼ºÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.
According to Stratistics MRC, the Global Remote Patient Monitoring Market is accounted for $72.52 billion in 2024 and is expected to reach $210.56 billion by 2030 growing at a CAGR of 25.6% during the forecast period. Remote patient monitoring is a healthcare technology that allows medical professionals to monitor patients outside of conventional clinical settings. It utilizes digital devices to collect medical data, such as vital signs, symptoms, and other health indicators, from patients in real-time. This information is transmitted securely to healthcare providers, enabling continuous monitoring and proactive intervention when necessary. RPM enhances patient care by facilitating early detection of health issues, improving treatment adherence, and reducing the need for frequent hospital visits.
According to the Centers for Disease Control and Prevention (CDC), over 100 million people have hypertension in the United States and The American Heart Association (AHA) supports initiatives that increase access to the use of Remote Patient Monitoring technologies (RPM) for better health management.
Increasing prevalence of chronic diseases
The increasing prevalence of chronic diseases globally, such as diabetes, cardiovascular diseases, and respiratory conditions, drives the growth of the remote patient monitoring (RPM) by creating a greater demand for continuous monitoring and management outside traditional healthcare settings. RPM allows for real-time monitoring of vital signs, symptoms, and health parameters remotely, enabling early detection of deteriorating health conditions and timely intervention. This proactive approach not only improves patient outcomes but also reduces healthcare costs associated with preventable hospitalizations and emergency room visits, making RPM an essential tool in chronic disease management strategies.
Limited reimbursement policies
Limited reimbursement policies in remote patient monitoring (RPM) often stem from challenges in establishing standardized reimbursement frameworks that account for the diverse RPM services and technologies available. These policies vary widely across regions and payers, leading to uncertainty and inconsistency in coverage for RPM services. This lack of clear and comprehensive reimbursement can deter healthcare providers and organizations from investing in RPM solutions, slowing market adoption and innovation.
Growing elderly population
As the elderly population increases, so does the prevalence of chronic conditions and age-related health issues requiring continuous monitoring and management. RPM technology allows healthcare providers to remotely monitor vital signs, medication adherence, and overall health status, facilitating early intervention and personalized care. This capability not only improves health outcomes for seniors but also enhances their quality of life by reducing the need for frequent clinic visits and hospitalizations, thereby addressing the challenges of aging populations efficiently and cost-effectively.
Technological barriers
Technological barriers in remote patient monitoring include issues with connectivity, interoperability between different devices and systems, and ensuring data security and privacy. These barriers can hinder seamless data transmission and real-time monitoring, impacting the reliability and effectiveness of RPM solutions. Moreover, user acceptance and usability issues with new technologies can slow adoption rates among healthcare providers and patients alike.
Covid-19 Impact
The covid-19 pandemic significantly boosted the remote patient monitoring market as healthcare providers sought to minimize in-person visits and reduce exposure risks. RPM adoption surged due to its ability to remotely monitor COVID-19 patients' vital signs and symptoms. This increased demand for RPM solutions, driving market growth and innovation. It also highlighted RPM's potential in managing healthcare delivery during crises, leading to expanded applications beyond the pandemic.
The wearable devices segment is expected to be the largest during the forecast period
The wearable devices segment is estimated to have a lucrative growth. Wearable devices play a pivotal role in remote patient monitoring by continuously tracking vital signs like heart rate, blood pressure, and activity levels. They enable healthcare providers to remotely monitor patients' health in real-time, detect anomalies early, and intervene promptly when necessary. These devices enhance patient care by providing data-driven insights into health trends and facilitating personalized treatment plans, ultimately improving outcomes and reducing healthcare costs.
The chronic disease management services segment is expected to have the highest CAGR during the forecast period
The chronic disease management services segment is anticipated to witness the fastest CAGR growth during the forecast period. Remote patient monitoring involves continuous tracking of patients' health data from a distance, enhancing proactive care. This approach utilizes digital technologies like wearable devices and mobile apps to monitor vital signs and symptoms remotely. Healthcare providers can intervene early, reducing hospitalizations and improving patient outcomes. It's a promising strategy in modern healthcare for managing conditions such as diabetes, hypertension, and heart disease efficiently.
In the Asia Pacific region, the remote patient monitoring market is experiencing substantial growth driven by increasing healthcare expenditure, rising prevalence of chronic diseases, and advancements in healthcare technology. Countries like Japan, China, India, and Australia are witnessing significant adoption of RPM solutions due to expanding elderly populations and the need for efficient healthcare management. Government initiatives promoting digital health solutions further propel market expansion. The market in Asia Pacific is poised for continued growth with ongoing technological advancements and healthcare reforms.
In North America, the remote patient monitoring market is robust and rapidly expanding. The region leads globally in RPM adoption due to advanced healthcare infrastructure, favourable reimbursement policies, and a high prevalence of chronic diseases such as diabetes and cardiovascular conditions. The United States and Canada are key contributors to market growth, driven by increasing healthcare costs and the shift towards value-based care models. The market is characterized by innovation, with ongoing developments in technology and regulatory frameworks supporting its growth.
Key players in the market
Some of the key players profiled in the Remote Patient Monitoring Market include Philips Healthcare, Medtronic, Abbott Laboratories, Boston Scientific Corporation, Apollo, Omron Healthcare, GE Healthcare, Honeywell Life Care Solutions, Biotricity Inc., iRhythm Technologies, Smiths Medical, Resideo Life Care Solutions, Masimo Corporation, Qualcomm Life and Garmin Health.
In January 2024, Apollo Hospital, a renowned multi-specialty hospital in Bangalore, announces a pioneering partnership with LifeSigns, a leading AI-powered health monitoring technology company.This collaboration empowers the hospital with a cutting-edge 24/7 wireless and remote patient monitoring system, marking a significant advancement in precision healthcare and proactive patient management.
In May 2023, Philips launched Virtual Care Management, a comprehensive portfolio of flexible solutions and services health systems, providers, payers, and employers to motivate and engage with patients from anywhere.